JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

Search

Alcon Inc

Chiusa

SettoreSettore sanitario

84.91 -0.64

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

84.49

Massimo

85.68

Metriche Chiave

By Trading Economics

Entrata

76M

350M

Vendite

-29M

2.5B

P/E

Media del settore

39.031

34.393

Rendimento da dividendi

0.38

Margine di Profitto

14.153

Dipendenti

25,000

EBITDA

-226M

463M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+24.44% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.38%

2.54%

Utili prossimi

19 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

3.6B

44B

Apertura precedente

85.55

Chiusura precedente

84.91

Notizie sul Sentiment di mercato

By Acuity

50%

50%

162 / 374 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

Alcon Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

5 ago 2025, 10:10 UTC

Acquisizioni, Fusioni, Takeovers

Alcon to Buy Staar Surgical for $1.5 Billion

14 mag 2025, 15:56 UTC

Utili
I principali Market Mover

Alcon Shares Fall After Lowering 2025 Outlook

26 mar 2025, 21:22 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Buys Majority Stake in Aurion to Advance Eye Disease Treatment

24 mar 2025, 12:36 UTC

Acquisizioni, Fusioni, Takeovers

Alcon to Buy Lensar in Deal Worth Up to $430 Million

8 ago 2025, 13:40 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Staar Surgical's Top Holder Questions Deal -- Market Talk

5 ago 2025, 05:07 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Deal Puts STARR Equity Value at Approximately $1.5 Billion. >ALC.EB

5 ago 2025, 05:07 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Will Purchase All Outstanding Shares of STAAR Common Stock for $28 Per Share in Cash >ALC.EB

5 ago 2025, 05:07 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Deal Represents 51% Premium to Closing Price of STAAR Common Stock on Aug. 4 >ALC.EB

5 ago 2025, 05:07 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Agrees to Acquire STAAR Surgical >ALC STAA

5 ago 2025, 05:01 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Agrees To Acquire STAAR Surgical >ALC STAA

7 lug 2025, 12:00 UTC

Acquisizioni, Fusioni, Takeovers

Alcon To Acquire LumiThera And Its Photobiomodulation Device For The Treatment Of Early And Intermediate Dry Age-Related Macular Degeneration (AMD) >ALC

30 mag 2025, 06:32 UTC

Discorsi di Mercato
Utili

Alcon's First FDA Approval Since Listing Is Positive, But Expected -- Market Talk

22 mag 2025, 20:46 UTC

Acquisizioni, Fusioni, Takeovers

Alcon and Lensar Receive FTC Requests for Additional Information About Merger

13 mag 2025, 20:32 UTC

Utili

Alcon Raises 2025 View To Sales $10.4B-$10.5B >ALC.EB

13 mag 2025, 20:31 UTC

Utili

Alcon 1Q Sales $2.45B >ALC.EB

13 mag 2025, 20:30 UTC

Utili

Alcon 1Q Rev $2.47B >ALC.EB

13 mag 2025, 20:30 UTC

Utili

Alcon 1Q EPS 70c >ALC.EB

8 apr 2025, 08:20 UTC

Discorsi di Mercato

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

26 mar 2025, 21:55 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Alcon Deal for Aurion Follows 2022 Investment, 2024 Lawsuit -- Market Talk

26 mar 2025, 20:33 UTC

Acquisizioni, Fusioni, Takeovers

Aurion Board Appoints Arnaud Lacoste as CEO of Aurion

26 mar 2025, 20:32 UTC

Acquisizioni, Fusioni, Takeovers

Alcon: Aurion Will Operate as a Separate Company With Full Support From Alcon to Advance Its Clinical-Stage Allogeneic Cell Therapy Asset

26 mar 2025, 20:32 UTC

Acquisizioni, Fusioni, Takeovers

Leverages Alcon's Global Scale With Aurion's Cell Therapy Expertise to Accelerate U.S. Phase 3 Development in Fall of 2025 >ALC.EB

26 mar 2025, 20:31 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Acquires Interest in Aurion to Advance Innovative Cell Therapy for Corneal Endothelial Disease >ALC.EB

26 mar 2025, 20:31 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Inc. Unit Alcon Research Previously Sued Aurion to Prevent It From Going Public

26 mar 2025, 20:31 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Acquires Majority Interest in Aurion Biotech >ALC.EB

26 mar 2025, 20:30 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Acquires Majority Interest in Aurion Biotech

24 mar 2025, 12:21 UTC

Acquisizioni, Fusioni, Takeovers

Alcon to Buy Lensar in Deal Worth Up to $430M

24 mar 2025, 12:05 UTC

Acquisizioni, Fusioni, Takeovers

Alcon: Transaction Is Anticipated to Close in Mid-To-Late 2025 >ALC

24 mar 2025, 12:05 UTC

Acquisizioni, Fusioni, Takeovers

Alcon: Transaction Represents a Total Consideration of Up to About $430M >ALC

24 mar 2025, 12:04 UTC

Acquisizioni, Fusioni, Takeovers

Alcon: Additional Non-Tradeable Contingent Value Right Offering Up to $2.75 Per Shr in Cash, Conditioned on Achievement of 614,000 Cumulative Procedures With LENSAR's Products Between Jan 1, 2026, and Dec 31, 2027 >ALC

Confronto tra pari

Modifica del prezzo

Alcon Inc Previsione

Obiettivo di Prezzo

By TipRanks

24.44% in crescita

Previsioni per 12 mesi

Media 106.71 USD  24.44%

Alto 123.933 USD

Basso 84 USD

Basato su 15 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Alcon Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

15 ratings

12

Acquista

3

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

95.77 / 97.61Supporto e resistenza

A breve termine

Bullish Evidence

A termine intermedio

Strong Bullish Evidence

A lungo termine

Strong Bullish Evidence

Sentiment

By Acuity

162 / 374 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.